The store will not work correctly when cookies are disabled.
methyl 3-(4-methoxyphenylamino)-2-(2-methyl-1H-imidazol-4-yl)imidazo[1,2-a]pyridine-6-carboxylate
ID: ALA4546478
PubChem CID: 155552323
Max Phase: Preclinical
Molecular Formula: C20H19N5O3
Molecular Weight: 377.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)c1ccc2nc(-c3c[nH]c(C)n3)c(Nc3ccc(OC)cc3)n2c1
Standard InChI: InChI=1S/C20H19N5O3/c1-12-21-10-16(22-12)18-19(23-14-5-7-15(27-2)8-6-14)25-11-13(20(26)28-3)4-9-17(25)24-18/h4-11,23H,1-3H3,(H,21,22)
Standard InChI Key: GLIOSOGDSIBUTD-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
44.2060 -3.9341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8704 -3.9303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5385 -4.4150 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.1251 -3.1451 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.9472 -3.1463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2439 -4.9734 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.6566 -3.7019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9911 -4.1889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.3262 -4.1889 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
46.0675 -4.9709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.6147 -5.5839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.4210 -5.4161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.6769 -4.6300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.1278 -4.0203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.6553 -2.8765 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
46.3695 -2.4627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.0818 -2.8758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.7955 -2.4627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.7947 -1.6363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.0742 -1.2249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.3634 -1.6404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
48.5084 -1.2216 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
49.2243 -1.6323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
48.4843 -4.4586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
49.0365 -5.0721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
49.8439 -4.9007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
48.7395 -3.6735 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.0855 -4.1858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 5 2 0
4 2 1 0
2 3 2 0
3 1 1 0
4 5 1 0
6 10 2 0
9 7 1 0
7 8 2 0
8 6 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
7 15 1 0
8 1 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 1 0
13 24 1 0
24 25 1 0
25 26 1 0
24 27 2 0
2 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 377.40 | Molecular Weight (Monoisotopic): 377.1488 | AlogP: 3.57 | #Rotatable Bonds: 5 |
Polar Surface Area: 93.54 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.71 | CX Basic pKa: 5.96 | CX LogP: 2.56 | CX LogD: 2.54 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.52 | Np Likeness Score: -1.40 |
References
1. (2018) Inhibitors of trim33 and methods of use, |